Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation

Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of t...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Gurkina, N. I. Stuklov, N. D. Kisly, R. R. Gimadiev, M. S. Kovalchuk
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2023-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3332
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839577747277479936
author A. A. Gurkina
N. I. Stuklov
N. D. Kisly
R. R. Gimadiev
M. S. Kovalchuk
author_facet A. A. Gurkina
N. I. Stuklov
N. D. Kisly
R. R. Gimadiev
M. S. Kovalchuk
author_sort A. A. Gurkina
collection DOAJ
description Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of the general group were divided into 3 subgroups depending on the serum ferritin (SF) and transferrin saturation (TS).Results. Anemia in HF is not always associated with iron deficiency (ID), characterized by inadequate production of erythropoietin, increased levels of C-reactive protein and hepcidin. From the general group of patients, the following were distinguished: absolute ID (43%), functional ID (19%), and non-ID anemia (38%).Conclusion. In the general group of patients with HF, anemia is normochromic, normocytic, characterized by high levels of C-reactive protein, hepcidin, and inadequate production of erythropoietin. Patients with absolute and functional ID do not differ in the main iron metabolism parameters and in general account for 62% (p=0,01). In these two subgroups, iron supplements should be prescribed at further stages.
format Article
id doaj-art-0d955b7c4d5c444d99c7cc4be41ddaf6
institution Matheson Library
issn 1728-8800
2619-0125
language Russian
publishDate 2023-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-0d955b7c4d5c444d99c7cc4be41ddaf62025-08-04T12:50:29Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252023-02-0122110.15829/1728-8800-2023-33322627Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammationA. A. Gurkina0N. I. Stuklov1N. D. Kisly2R. R. Gimadiev3M. S. Kovalchuk4Peoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; National Medical Research Center of RadiologyPeoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; Eurotest, OOOPeoples’ Friendship University of RussiaAim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of the general group were divided into 3 subgroups depending on the serum ferritin (SF) and transferrin saturation (TS).Results. Anemia in HF is not always associated with iron deficiency (ID), characterized by inadequate production of erythropoietin, increased levels of C-reactive protein and hepcidin. From the general group of patients, the following were distinguished: absolute ID (43%), functional ID (19%), and non-ID anemia (38%).Conclusion. In the general group of patients with HF, anemia is normochromic, normocytic, characterized by high levels of C-reactive protein, hepcidin, and inadequate production of erythropoietin. Patients with absolute and functional ID do not differ in the main iron metabolism parameters and in general account for 62% (p=0,01). In these two subgroups, iron supplements should be prescribed at further stages.https://cardiovascular.elpub.ru/jour/article/view/3332heart failureanemiairon deficiency syndromesferritinerythropoietinhepcidin
spellingShingle A. A. Gurkina
N. I. Stuklov
N. D. Kisly
R. R. Gimadiev
M. S. Kovalchuk
Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
Кардиоваскулярная терапия и профилактика
heart failure
anemia
iron deficiency syndromes
ferritin
erythropoietin
hepcidin
title Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
title_full Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
title_fullStr Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
title_full_unstemmed Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
title_short Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
title_sort characteristics of anemia in heart failure iron metabolism erythropoietic activity and markers of inflammation
topic heart failure
anemia
iron deficiency syndromes
ferritin
erythropoietin
hepcidin
url https://cardiovascular.elpub.ru/jour/article/view/3332
work_keys_str_mv AT aagurkina characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation
AT nistuklov characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation
AT ndkisly characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation
AT rrgimadiev characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation
AT mskovalchuk characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation